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Abstract Chronic mid-portion Achilles tendinopathy is
generally difﬁcult to treat as the background to the pain
mechanisms has not yet been clariﬁed. A wide range of
conservative and surgical treatment options are available.
Most address intratendinous degenerative changes when
present, as it is believed that these changes are responsible
for the symptoms. Since up to 34% of asymptomatic ten-
dons show histopathological changes, we believe that the
tendon proper is not the cause of pain in the majority of
patients. Chronic painful tendons show the ingrowth of
sensory and sympathetic nerves from the paratenon with
release of nociceptive substances. Denervating the Achilles
tendon by release of the paratenon is sufﬁcient to cause
pain relief in the majority of patients. This type of treat-
ment has the additional advantage that it is associated with
a shorter recovery time when compared with treatment
options that address the tendon itself. An evidence-based
philosophy on the cause of pain in chronic mid-portion
Achilles tendinopathy is presented.
Level of evidence V.
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Introduction
Chronic Achilles tendon pathology is one of the most
frequent injuries in sports involving running and jumping.
In elite long-distance runners, there is a lifetime risk of
52% for sustaining an Achilles tendon injury [39]. Thirty
per cent of patients have a sedentary lifestyle [7].
Chronic mid-portion Achilles tendinopathy [78]i s
characterised by impaired performance due to Achilles
tendon pain and swelling located typically at 2–7 cm from
the insertion onto the calcaneus [48]. The source of pain
and the background to the pain mechanisms associated
with mid-portion Achilles tendinopathy have not yet been
clariﬁed [49]. Many different explanations have been
raised. Consequently, a wide range of conservative and
surgical treatment options are available. Most of them
address the intratendinous degenerative changes when
present. Surgical measures include open excision of
degenerative tendon. This means that the intratendinous
changes are found responsible for the symptoms. But does
the origin of the pain in these patients indeed rise from the
Achilles tendon itself? It is known that the tendon itself is
relatively aneuronal. It is also recognised that intratendi-
nous degenerative changes often occur without symptoms.
It is hypothesised that the main cause of the pain in
patients with symptomatic mid-portion Achilles tendinop-
athy does not arise from the tendon proper but is generated
by its surrounding tissues. In this paper, a premise on the
cause of pain based on existing knowledge and personal
research is presented.
Anatomy
The Achilles tendon is the combination of tendons of soleus
and gastrocnemius muscles, inserting approximately half-
way the calcaneus. The gastrocnemius muscle crosses the
knee, subtalar and ankle joints, originating from the pos-
teriormedialandlateralfemoralcondylesandinsertingonto
the calcaneus. The soleus muscle lies anterior to the
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tibia, ﬁbula and interosseous membrane and crosses the
ankle and subtalar joints. Distally, both the gastrocnemius
andsoleusmusclesformanaponeurosis,fromeachofwhich
a tendon originates. At about the level where the soleus
contributes ﬁbres to the Achilles tendon, rotation of the
tendon begins and becomes more marked 2–7 cm proximal
to the insertiononto the calcaneus. The gastrocnemiusﬁbres
rotate tolateralandthe soleusﬁbres arepositionedmedialto
the insertion [9, 21, 57]. Medial to the Achilles tendon the
plantaris tendon is located, originating from the lateral
femoral condyle and inserting onto the medial calcaneus.
The Achilles tendon is involved in plantarﬂexion, whereas
according to its anatomical course, the triarticular plantaris
tendon also contributes to ankle inversion.
The Achilles and plantaris tendon are collectively sur-
rounded by a paratenon, which lies on an inner layer of
endotenon and exists on a layer of mesotenon and an outer
layer of epitenon.
Tendon consists predominantly of extracellular tissue
with low metabolic requirements and therefore appears
white on macroscopic inspection. This relatively brady-
trophic character enables the tendon to remain under ten-
sion for a long period, without the risk of necrosis or
ischaemia. The Achilles tendon has 3 sources of vascular
supply, which are (1) the perimyseal vessels at the mus-
culotendinous junction; (2) periosteal vessels at the osteo-
tendinous junction; and (3) vessels around the tendon
within the paratenon, forming a capillary loop system. This
last system is the main vascular supply for the Achilles
tendon. The neural supply to the Achilles tendon and the
surrounding paratenon is provided by nerves from the
attaching muscles and by small fasciculi from cutaneous
nerves, in particular the sural nerve [9, 71]. The number of
nerves and nerve endings is relatively low, and the tendon
proper is relatively aneuronal [43, 65].
Aetiology
A distinction is made between the aetiology of intratendi-
nous degenerative changes and the aetiology of complaints
in patients with mid-portion Achilles tendinopathy. Causes
of intratendinous changes can be divided into extrinsic and
intrinsic factors, but most commonly will be a combination
of both. Malalignment of the foot, hyperpronation [63, 68],
age [45] and chronic disease like diabetes mellitus, obesity
and hypertension [28] have been described. Malalignment
and hyperpronation impose excessive strain on the Achilles
tendon. The ageing tendon loses its elastic properties
causing the muscle to work more, resulting in a local rise in
temperature with subsequent tendon changes [68].
Inappropriate physical training may also be an important
issue [37, 46] causing degenerative Achilles tendon chan-
ges. Tendons transmit muscle forces to bone, allowing
locomotion and enhancing joint stability. They respond to
mechanical forces by changing their metabolism and their
structural and mechanical properties. Appropriate training
increases the diameter and tensile strength of tendons, with
tendon ﬁbroblasts increasing the production of collagen
type I [42, 53, 72, 75]. Training also induces biochemical
changes in tendons. Strenuous endurance training increases
collagen turnover and decreases collagen maturation in
tendons; excessive mechanical loading is considered a
major concern. Repetitive strains below the failure
threshold of the tendon cause tendon micro-injuries [38,
61]. Quality of foot gear and training surface inﬂuencing
the alignment and statics of the ankle are also often men-
tioned as a cause of intratendinous pathology.
The aetiology of the pain in a patient with mid-portion
Achilles tendinopathy has not yet been entirely clariﬁed.
Pain was believed to be caused by expansion of the
Achilles tendon proper due to increased ground substance
and an increased concentration of glucosaminoglycans
(GAGs). A few years ago, the presence of neovasculari-
sation around symptomatic tendons was raised as the cause
of pain; now accompanying nerves with high concentra-
tions of nociceptive substances [glutamate, substance P,
calcitonin gene-related peptide (CGRP)] are also supposed
to play a role [5, 8].
Clinical presentation
Symptoms of a patient with mid-portion Achilles tendin-
opathy include painful swelling typically 2–7 cm proximal
to the insertion and stiffness especially when getting up
after a period of rest. Pain is the main symptom in Achilles
tendinopathy that leads a patient to seek medical help. It is
often most prominent 2–7 cm from the insertion onto the
calcaneus on the medial side [67]. Tendinopathy and pa-
ratendinopathy often coexist [64]. Intratendinous changes
most often remain asymptomatic [35]. In these cases, a
painless swelling at 2–7 cm proximal to the insertion is the
only ﬁnding [58]. In isolated paratendinopathy, there is
local thickening of the paratenon. The area of swelling
does not move with dorsiﬂexion and plantarﬂexion of the
ankle, where it does in isolated tendinopathy [50, 69, 82].
Paratendinopathy can be acute or chronic. Acute isolated
paratendinopathy manifests itself as painful peritendinous
crepitus as the tendon glides within the inﬂamed covering.
Areas of increased erythema, local heat and asymptom-
atic palpable tendon nodules or defects may also be pres-
ent at clinical examination. In chronic paratendinopathy,
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tion and swelling diminish.
Histopathology
Normal situation
Morphologically, healthy tendon is a complex composite
material consisting of collagen ﬁbrils embedded in a matrix
of proteoglycans, with a relatively small number of cells.
Between the parallel collagen bundles, ﬁbroblasts are
arranged, which are the predominant cells within tendons
[10]. The matrix has tight bundles of long strands of type I
collagen, which give the tendon its inherent strength.
Between the collagen is the ground substance, made up of
mainly small proteoglycans and glycosaminoglycan (GAG)
chains. In normal tendon, there is minimal ground sub-
stance [14].
The paratenon consists of straight bundles of type I and
type III collagen ﬁbrils with straight microﬁbrillar
arrangement and variable diameter [23, 41]. This periten-
dinous tissue is lined on its inner surface by synovial cells
[31, 82] and acts as an elastic sleeve permitting the
movement of tendon against the surrounding tissues [34].
The paratenon serves to carry blood vessels, lymphatics
and nerves.
Pathological situation
In contrast to the white appearance of healthy tendon, in
tendinopathy they macroscopically appear grey or yellow-
brown and amorphous. Microscopically, the tendon shows
disrupted collagen, a decrease in the amount of type I
collagen and an increase in the amount of the weak type III
collagen that is produced in response to injury and is less
able to bundle. The classical hierarchical structure is lost,
and there is increased ground substance with a high con-
centration of GAGs, more prominent and numerous teno-
cytes without their normal ﬁne spindle shape and more
rounded nuclei [14, 24]. Some areas of tendinopathy
become acellular [36] or have decreased cell numbers and
function [14, 33].
In the peritendinous tissue in the chronic phase of
Achilles tendinopathy, 2 types of cells have been identiﬁed:
ﬁbroblasts and myoﬁbroblasts [41]. During biological
processes that include extensive tissue remodelling, ﬁbro-
blasts may acquire morphological and biochemical features
of contractile cells, which have been named myoﬁbroblasts
[20]. The myoﬁbroblasts have stress ﬁbres composed of
a-smooth muscle actin in their cytoplasm and thus are
capable of creating forces required for wound contraction
[20]. In chronic Achilles tendinopathy, these cells are
especially well established at the sites of scar formation,
and it is estimated that about 20% of peritendinous cells are
myoﬁbroblasts [41]. The myoﬁbroblasts synthesise abun-
dant amounts of collagen and are believed to be responsible
for the formation of permanent scarring and the shrinkage
of peritendinous tissue around the tendon [30, 41]. They
can induce and maintain a prolonged contracted state in the
peritendinous adhesions around the tendon and thus inﬂu-
ence the development of a contracture [30, 41]. This, in
turn, may lead to the constriction of vascular channels and
to impaired circulation and further contribute to the path-
ogenesis of Achilles tendinopathy. The proliferating con-
nective tissue around the Achilles tendon causes increased
intratendinous tension and pressure resulting in increased
friction between the tendon, paratenon, crural fascia and
the skin [30].
Vascularity seems increased in tendinopathy, as neo-
vascularisation with thick walls, a tortuous appearance and
small lumen ventral from the Achilles tendon and in the
paratenon is found in 50–88% of symptomatic tendons but
not in pain-free tendons [18, 59, 60, 80, 83].
The healthy Achilles tendon proper is superﬁcially
innervated by the paratenon, but does not have a rich
nervous supply itself [8]. It is normally aneuronal; con-
versely, chronic painful tendons have been shown to
exhibit new ingrowth of nerve ﬁbres accompanying the
peritendinous neovascularisation from the paratenon into
the tendon proper [43, 65]. Sensory nerve ingrowth has
been observed as a reaction to repetitive loading [52] and
also as a response to injury [2, 4]. With this nerve ingrowth,
levels of glutamate, calcitonin gene-related peptide
(CGRP) and substance P rise [4, 8, 43, 65]. These sub-
stances are all linked with increased nociception. Substance
P is also associated with vasodilation and stimulates the
proliferation of ﬁbroblasts [70], possibly causing some of
the morphologic changes in Achilles tendinopathy.
Cause of pain
Several factors play a role in the cause of pain in a patient
with Achilles tendinopathy.
The process starts with localised tendon micro-injury
and degeneration, which are caused by ageing and repeti-
tive strain below the failure threshold of the tendon. The
most hypovascular region is in the mid-portion area
(2–7 cm from the insertion), where the tendon makes a
marked twist. This is the location where the degeneration
and micro-injury most often occur. Blood ﬂow further
declines with ageing and mechanical loading. When the
demands of the tendon are higher than can be managed,
micro-injuries develop [1]. The body reacts with a repair
process, which is adequate in most cases, but inadequate in
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causes a repetitive cycle of inadequate collagen and matrix
production, tenocyte disruption, a further decrease in col-
lagen and matrix and an increased vulnerability to further
micro-injuries. Due to the lack of blood vessels within the
tendon, instead of a chemical, a neurogenic inﬂammatory
process is activated to repair these microruptures. This
neurogenic inﬂammation occurs in the tissue surrounding
the Achilles tendon. Matrix metalloproteinases (MMPs)
responsible for the degradation of extracellular matrix,
cytokines [vascular endothelial growth factor (VEGF),
epidermal growth factor (EGF) and platelet-derived growth
factor (PDGF)] are overexpressed. VEGF promotes angi-
ogenesis, upregulates the expression of MMPs and down-
regulates tissue inhibitors of metalloproteinases (TIMP-3),
altering the properties of tendon. Invasion of vessels
derived from the paratenon into a normally hypovascular
intratendinous region weakens the normal tendon structure.
When the repair of tendon is inadequate, e.g. due to sub-
mission to further loads without adequate recovery time or
a declined blood ﬂow due to ageing, the healing process
fails and the pathogenic cascade leading to symptomatic
tendinopathy occurs. The transition to symptomatic ten-
dinopathy is marked by nerve proliferation accompanying
the neovessels. Vascular ingrowth to repair the defect
arises from the paratenon. These blood vessels are
accompanied by sensory neonerves [11, 22] (Fig. 1),
causing an increase in pain signalling by producing noci-
ceptive substances [glutamate, substance P, calcitonin
gene-related peptide (CGRP)] past the critical threshold [5,
8]. Neovascularisation has indeed been found to correlate
with the location of pain in patients with symptomatic
tendinopathy [19]. The upregulated nociceptive substances
further damage the tendon by inducing vasodilation, tendon
cell apoptosis and the vicious circle of neurogenic
inﬂammation [1, 5, 8, 22, 54].
Myoﬁbroblasts proliferate and are transported by the
peritendinous blood vessels and neovascularisation into the
peritendineum and the tendon proper. Myoﬁbroblasts not
only synthesise abundant amounts of collagen to repair the
tendon proper but also cause the formation of scar tissue
around the tendon and consequently adhesions of the par-
atenon onto the Achilles tendon at the location of the
neurovascular ingrowth. Scarring in turn may lead to the
constriction of vascular channels and to impaired circula-
tion and further contribute to the pathogenesis of Achilles
tendinopathy, meaning that there is no further action
towards repair.
Vasoconstriction and scarring with mechanical con-
striction will lead to the obliteration of neovessels. In
20–50% of long-lasting tendinopathy patients, no neovas-
cularisation is found [18, 59, 60, 80, 83]. Nerves, however,
will survive (Fig. 2), secreting glutamate and substance P
causing pain on activity as described earlier.
Reduction in blood ﬂow may also be explained by the
fact that pathological tendons also exhibit a decreased
occurrence of sympathetic nerve ﬁbres. This reduction in
vasoregulatory noradrenalin causes vasoconstriction [3].
It has been described that the location of the pain in
patients with Achilles tendinopathy is most often located
on the medial side [67, 69]. During Achilles tendoscopy in
patients with Achilles tendinopathy, it has been observed
that at the level of complaints the plantaris tendon is
afﬁxed onto the Achilles tendon on the medial side [69]
(Fig. 3). Some authors describe a higher medial stress onto
the Achilles tendon due to hyperpronation. This is sup-
ported by the ﬁnding that most ultrasonographic mid-por-
tion disorders (91%) are found in the posteromedial
segment of the tendon [26, 79].
In patients with a painful nodular thickening in the
Achilles tendon, the pain is often most prominent on the
medial side of the mid-portion Achilles tendon. At this
level, the plantaris tendon runs closely with and parallel to
the Achilles tendon.
The plantaris tendon originally is a knee and ankle
ﬂexor. In primates, it attaches to the plantar aspect of the
proximal interphalangeal joints of the toes in primates,
explaining its functionality for grasping with their feet.
Fig. 1 a Schematic depiction of normal tendon. b Pathological tendon proper. c Vasculoneuronal ingrowth from the paratenon into the tendon
proper
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plantaris tendon is rudimental since human beings do not
grasp with feet nor swing from trees any longer. Absence in
7–20% human lower limbs has been reported [16, 17, 25,
55, 66].
In humans, the plantaris muscle is triangularly shaped
and lies posterior to the knee joint, originating from the
inferior part of the lateral supracondylar line of the femur.
Its tendon travels inferomedially, posterior to the soleus
muscle and anterior to the medial gastrocnemius muscle.
The tendon crosses the calf relatively proximal, running
medial from and parallel with the Achilles tendon from the
mid-portion of the calf, in the majority of cases ultimately
inserting medially onto the calcaneus [17, 27]. The plan-
taris muscle–tendon complex nowadays is a weak ankle
and knee ﬂexor and ankle inverter.
The medial portion of the Achilles tendon consists
solely of the soleus tendon since at about the level where
the soleus contributes ﬁbres to the Achilles tendon
(3–11 cm), rotation of the tendon begins and becomes
more marked in the distal 5–6 cm. Gastrocnemius ﬁbres
are therefore positioned lateral and the soleus ﬁbres on the
medial side of the insertion (Fig. 3). The soleus is biar-
ticular (ankle and subtalar joints). The plantaris tendon runs
anteromedial to it. It is believed that in a healthy situation,
the plantaris tendon can move freely in relation to the
Achilles tendon. Adhesions between plantaris and Achilles
tendon can be the result of an inﬂammatory response of the
paratenon, which is located around the Achilles and plan-
taris tendons.
The plantaris muscle–tendon complex not only causes
ﬂexion but also inversion, whereas the triceps surae is a
ﬂexor only. Adhesions between both tendons obstruct the
opposite forces of these two bi and triarticular muscle
Fig. 2 a Adhesion of the
paratenon onto the Achilles
tendon due to myoﬁbroblast
proliferation and consequently
formation of scar tissue.
b Continuing ingrowth of
vessels and nerves and
augmented adhesion.
c Obliteration of neovessels due
to constriction. d The painful
end situation in which
neovascularisation has been
mostly obliterated but nerve
endings persist
Fig. 3 The most common position (52%) of the gastrocnemius–
soleus complex at the mid-portion of the Achilles tendon [15].
(PT = plantaris tendon, S = soleus, GC = gastrocnemius)
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limited, traction onto the surrounding paratenon will take
place with every step with a mean of 5,000–12,500 steps/
day in people with a low active to active lifestyle [76, 77].
Chronic painful tendons have been shown to exhibit new
ingrowth of sensory nerve ﬁbres from the paratenon [43,
65]. Repetitive traction onto this richly innervated area
might contribute to the medially located pain and stiffness
during and after walking.
Surgical treatment
Most surgical procedures aim at debridement or tenotomy
of the tendon itself. In all these procedures, the paratenon is
incised, released or removed as well. In open surgical
debridement of the tendon proper, the paratenon has to be
opened [32, 40, 47, 62], and during minimally invasive
tenotomy, the paratenon is also addressed. It is therefore
uncertain which part of the procedure is responsible for a
possible favourable outcome of such an approach.
Paratendinopathy and tendinopathy often coexist. In some
procedures, only peritendinous structures are addressed,
such as in open or minimally invasive paratenectomy [44,
56] and Achilles tendoscopy where the paratenon is
released and the plantaris tendon cut to relieve symptoms
(Fig. 4)[ 51, 69]. These procedures render good results not
in all but in 75–100% of patients. After treatment, most
often functional and recovery time, although not often
described, is 6 weeks to 6 months [44, 51, 69, 74]. With
Fig. 4 Endoscopic image of a
patient with medial pain of his
rightAchillestendonduetomid-
portion Achilles tendinopathy.
On Achilles tendoscopy, the
paratenon is released from the
Achillestendonandinthisimage
the plantaris tendon is identiﬁed.
aTheplantaristendonisattached
to the Achilles tendon. b With a
trocar (in this case), the plantaris
tendon is released from the
Achilles tendon
Fig. 5 The rationale of Achilles
tendoscopy. a With a blunt
trocar, the paratenon is released
from the Achilles tendon,
b thereby the nerves are
destructed. c The plantaris
tendon is cut at the level of
complaints. d In the
postoperative weeks, remnants
of nerves obliterate and the
proximal end of the plantaris
tendon retracts
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123surgery of the tendon proper, including minimally invasive
tenotomy, the tendon is temporarily weakened. Recovery
time until sport resumption therefore can be extensive and
takes 3–18 months [12, 73, 81].
How can the favourable results of addressing the para-
tenon only in patients with symptomatic Achilles tendin-
opathy be explained? Pain relief could be explained by the
destruction of the sensory nerves running from the para-
tenon into the Achilles tendon proper in these chronic
patients: denervation of the Achilles tendon by releasing
the paratenon may be the most important part of all these
procedures (Fig. 5).
Positive results obtained from the more invasive con-
servative treatments may also be contributable to the
destruction of nerve ﬁbres. For example, sclerosing injec-
tions with polidocanol and high-volume image-guided
injections (HVIGI) aim at obliterating neovessels and the
accompanying nerve ﬁbres [6, 13, 29].
If pain can be relieved with denervation, extensive
surgery of the tendon proper becomes redundant.
Conclusion
The goal of treatment of patients with chronic complaints
of mid-portion Achilles tendinopathy is to relieve pain.
Many surgical procedures focus on the debridement of
alterations in the tendon proper. Since up to 34% of
asymptomatic tendons show histopathological changes, it
is now believed that the tendon proper is not the cause of
pain in the majority of patients with symptomatic mid-
portion Achilles tendinopathy. Chronic painful tendons
show ingrowth of sensory and sympathetic nerves from the
paratenon with the release of nociceptive substances.
Denervating the Achilles tendon by release of the para-
tenon is sufﬁcient to cause pain relief in the majority of
patients. This type of treatment has the additional advan-
tage that it is associated with a shorter recovery time when
compared with treatment options that address the tendon
itself.
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